Thought Leaders: Berkadia Medical & Life Sciences – Summer 2024 Research Report

MEDICAL & LIFE SCIENCES REPORT

SUMMER 2024 | BERKADIA RESEARCH

Medical & Life Sciences Research Report

Berkadia is pleased to present our latest Medical & Life Sciences Research Report, analyzing data from the first half of 2024.

The medical and life sciences industry encompasses a broad range of sectors involved in the research, development, manufacturing, and delivery of healthcare products, services, and technologies.

This report explores trends in the debt market, healthcare and life sciences capital, legislation and more to uncover their impact on the sector and what may lie ahead in the latter half of 2024.

Key Takeaways

• Revenue & Occupancy: The average occupancy rate for MOBs in the top 100 markets rose 59 basis points annually as trailing 12-month completions were largely absorbed in the second quarter of 2024.
• Health System Performance: During fiscal year 2023, the 10 largest systems (by number of hospitals) performed better than the national benchmarks for net operating profit margin and net income margins.
• Construction: While the fundamental demand for medical services continues to put pressure on healthcare providers, high construction costs and interest rates continued to moderate the development of new hospitals and medical outpatient buildings.
• Sales: The 12-month transaction volume returned closer to the pre-pandemic average in the second quarter of 2024, with just over $20.5 billion in medical outpatient buildings and hospitals trading hands.

DOWNLOAD REPORT

SUCCESS IS NOT PURELY MEASURED BY NUMBERS

BUT THEY HELP TELL OUR STORY*

INVESTMENT SALES VOLUME
$6.5B
Medical & Life Sciences Investment sales since 2018

MORTGAGE BANKING VOLUME
$2B
Medical & Life Sciences loan originations since 2018

RECAPITALIZATIONS
$2.7B
Medical & Life Sciences porfolio and single-asset recapitalizations since 2018

NATIONAL PRESENCE
45
states in which we’ve closed transactions

* Team career production stats

CONTACT US

HEAD OF MEDICAL & LIFE SCIENCES

SABRINA SOLOMIANY
Senior Managing Director
404.536.5054
Email me

INVESTMENT SALES

CHRIS LASHMET
Managing Director
847.209.0425
Email me

ERIC LEE
Managing Director
763.226.8563
Email me

VASILI DAVOS
Senior Director
214.360.3858
Email me

MORTGAGE BANKING

MIKE CERNY
Vice President
904.296.7565
Email me

PATRICK ABELN
Director
312.845.8573
Email me

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In